Monitoring bromide loss in bromoacetyl-derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB® by capillary electrophoresis and NMR spectroscopy.

Saved in:
Bibliographic Details
Title: Monitoring bromide loss in bromoacetyl-derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB® by capillary electrophoresis and NMR spectroscopy.
Authors: Rustandi RR; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: richard_rustandi@merck.com., Hamm M; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA., Onimus M; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA., Yuan Y; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA., Anderson CL; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA., Zong C; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA.
Source: Vaccine [Vaccine] 2022 Oct 06; Vol. 40 (42), pp. 6012-6016. Date of Electronic Publication: 2022 Sep 17.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2022.09.026